MedPath

SULCRATE SUSPENSION PLUS

SULCRATE SUSPENSION PLUS

Approved
DIN Number

02103567

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02103567
AIG Number0114237003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BX02 SUCRALFATE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification56:28.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

SUCRALFATEActive
Strength: 1 G / 5 ML
Monograph: SUCRALFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.